Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells

Clinical Cancer Research

Volumn 10, Issue 2, 2004, Pages 581-590

  Fukahi, Kimi ^a   Fukasawa, Mitsuharu ^a   Neufeld, Gera ^b   Itakura, Jun ^c   Korc, Murray ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LIGAND; MESSENGER RNA; NEUROPILIN 1; NEUROPILIN 2; TUNICAMYCIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ACINAR CELL; ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL STRAIN ASPC 1; CELL STRAIN CAPAN 1; CELL STRAIN COS7; CELL STRAIN PANC 1; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS CANCER; PANCREAS CANCER CELL; PANCREAS DUCT; PANCREAS DUCTAL CARCINOMA; PANCREAS ISLET CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; COS CELLS; DNA, COMPLEMENTARY; GLYCOSYLATION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; LASERS; LIGANDS; NEUROPILIN-1; NEUROPILIN-2; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TRANSFECTION; TUNICAMYCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0842268386     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0930-03     Document Type: Article

References (47)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics CA. Cancer J. Clin., 47: 5-27, 1997.
2. Korc, M. Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. N. Am., 7: 25-41, 1998.
3. Luo, J., Guo, P., Matsuda, K., Truong, N., Lee, A., Chun, C., Cheng, S. Y., and Korc, M. Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo. Int. J. Cancer, 92: 361-369, 2001.
4. Ferrara, N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med., 77: 527-543, 1999.
5. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
6. Shibuya, M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct. Funct., 26: 25-35, 2001.
7. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
8. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92: 735-745, 1998.
9. Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., and Fujisawa, H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development, 121: 4309-4318, 1995.
10. Karkkaine, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., Yla-Herttuala, S., Finegold, D. N., Ferrell, R. E., and Alitalo, K. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA, 98: 12677-12682, 2001.
11. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., and Neufeld, G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J. Biol. Chem., 275: 18688-18694, 2000.
12. Itakura, J., Ishiwata, T., Friess, H., Fujii, H., Matsumoto, Y., Büchler, M. W., and Korc, M. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin. Cancer Res., 3: 1309-1316, 1997.
13. Ellis, L. M., Takahashi, Y., Fenoglio, C. J., Cleary, K. R., Bucana, C. D., and Evans, D. B. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur. J. Cancer, 34: 337-340, 1998.
14. Seo, Y. B. H., Fukuda, T., Takashima, M., and Sugimachi, K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer (Phila.), 88: 2239-2245, 2000.
15. Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., Nakano, H., and Miyake, M. Prognostic significance of angiogenesis in human pancreatic cancer. Br. J. Cancer, 79: 1553-1563, 1999.
16. Itakura, J., Ishiwata, T., Shen, B., Kornmann, M., and Korc, M. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int. J. Cancer, 85: 27-34, 2000.
17. von Marschall, Z., Cramer, T., Hocker, M., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E. O., Wiedenmann, B., and Rosewicz, S. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology, 119: 1358-1372, 2000.
18. Kleeff, J., Fukahi, K., Lopez, M. E., Friess, H., Buchler, M. W., Sosnowski, B. A., and Korc, M. Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors. Cancer Gene. Ther., 9: 522-532, 2002.
19. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., and Neufeld, G. Neuropilin-2 and Neuropilin-1 are receptors for 165-amino acid long form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145 amino acid form of VEGF. J. Biol. Chem., 275: 18040-18045, 2000.
20. Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H. Q., Takashima, S., Soker, S., and Klagsbrun, M. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity. Proc. Natl. Acad. Sci. USA, 97: 2573-2578, 2000.
21. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Büchler, M., and Beger, H. G. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Investig., 90: 1352-1360, 1992.
22. Wildi, S., Kleeff, J., Maruyama, H., Maurer, C. A., Friess, H., Büchler, M. W., Lander, A. D., and Korc, M. Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer. Clin. Cancer Res., 5: 2840-2847, 1999.
23. Baker, C. H., Solorzano, C. C., and Fidler, I. J. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res., 62: 1996-2003, 2002.
24. Witte, L., Hicklin, D. J., Zhu, Z., Pytowski, B., Kotanides, H., Rockwell, P., and Bohlen, P. Monoclonal antibodies targeting the VEGF receptor-2 (Flk-1/KDR) as an anti-angiogenetic therapeutic strategy. Cancer Metastasis Rev., 17: 155-161, 1998.
25. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thomas, K. A., and Curiel, D. T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. USA, 95: 8795-8800, 1998.
26. Fong, T. A., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T. J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K. P., and McMahon, G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res., 59: 99-106, 1999.
27. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 380: 439-442, 1996.
28. Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki, Ji, J., Hirota, S., Kitamura, Y., Kitsukawa, T., Fujisawa, H., Klagsbrun, M., and Hori, M. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA, 99: 3657-3662, 2002.
29. Tordjman, R., Lepelletier, Y., Lemarchandel, V., Cambot, M., Gaulard, P., Hermine, O., and Romeo, P. H. A neuronal receptor, neuropilin-1, is essential for the initiation of the ptimary immune response. Nat. Immunol., 3: 477-482, 2002.
30. Bachelder, R. E., Crago, A., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G., and Mercurio, A. M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res., 61: 5736-5740, 2001.
31. Enholm, B., Paavonen, K., Ristimaki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., Eriksson, U., and Alitalo, K. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene, 14: 2475-2483, 1997.
32. Ohm, J. E., and Carbone, D. P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res., 23: 263-272, 2001.
33. Fuh, G., Garcia, K. C., and de Vos, A. M. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J. Biol. Chem., 275: 26690-26695, 2000.
34. Whitaker, G. B., Limberg, B. J., and Rosenbaum, J. S. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J. Biol. Chem., 276: 25520-25531, 2001.
35. Gluzman-Poltorak, Z., Cohen, T., Shibuya, M., and Neufeld, G. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J. Biol. Chem., 276: 18688-18694, 2001.
36. Miao, H. Q., Lee, P., Lin, H., Soker, S., and Klagsbrun, M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J., 14: 2532-2539, 2000.
37. Latil, A., Bieche, I., Pesche, S., Valeri, A., Fournier, G., Cussenot, O., and Lidereau, R. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int. J. Cancer, 89: 167-171, 2000.
38. Banerjee, S. K., Zoubine, M. N., Tran, T. M., Weston, A. P., and Campbell, D. R. Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells. Int. J. Oncol., 16: 253-260, 2000.
39. Yuan, L., Moyon, D., Pardanaud, L., Breant, C., Karkkainen, M. J., Alitalo, K., and Eichmann, A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development, 129: 4797-4806, 2002.
40. Tang, R. F., Itakura, J., Aikawa, T., Matsuda, K., Fujii, H., Korc, M., and Matsumoto, Y. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas, 22: 285-292, 2001.
41. Dias, S., Choy, M., Alitalo, K., and Rafii, S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood, 99: 2179-2184, 2002.
42. Fakhari, M., Pullirsch, D., Abraham, D., Paya, K., Hofbauer, R., Holzfeind, P., Hofmann, M., and Aharinejad, S. Selective upregulation of vascular endothelial growth factor receptors neuropilin-1 and -2 in human neuroblastoma. Cancer (Phila.), 94: 258-263, 2002.
43. Kawakami, T., Tokunaga, T., Hatanaka, H., Kijima, H., Yamazaki, H., Abe, Y., Osamura, Y., Inoue, H., Ueyama., Y. and Nakamura, M. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer (Phila.), 95: 2196-2201, 2002.
44. Matthies, A. M., Low, Q. E., Lingen, M. W., and DiPietro, L. A. Neuropilin-1 participates in wound angiogenesis. Am. J. Pathol., 160: 289-296, 2002.
45. Cohen, T., Herzog, Y., Brodzky, A., Greenson, J. K., Eldar, S., Gluzman-Poltorak, Z., Neufeld, G., and Resnick, M. B. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours. J. Pathol., 198: 77-82, 2002.
46. Trompezinski, S., Pernet, I., Schmitt, D., and Viac, J. UV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblasts. Inflamm. Res., 50: 422-427, 2001.
47. Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Enamorado, I., Yeh, N. T., Kroog, G. S., Rudy, S., McCullagh, L., Mousa, S., Quezado, M., Herscher, L. L., and Van Waes, C. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res., 5: 1369-1379, 1999.